BiotechTube
Home/AI Proteins/Chris Bahl, MS, PhD
CB

Chris Bahl, MS, PhD

President, Chief Executive Officer, Founder

AI Proteins

Therapeutic Areas

Immunology & InflammationOncologyMetabolic

AI Proteins Pipeline

DrugIndicationPhase
TNFR1 AntagonistImmunology & InflammationDiscovery
Undisclosed Immune ActivatorOncologyDiscovery
Undisclosed Targeted RadiotherapyOncologyDiscovery
Undisclosed Program 1 (BMS)UndisclosedDiscovery
Undisclosed Program 2 (BMS)UndisclosedDiscovery

Leadership Team at AI Proteins

BM
Ben Meinen, MS, PhD
Investigator, Head of Protein Design
AA
Alyssa Anderson, PhD
Investigator, Head of Protein Characterization
AV
Arturo Vera Rodriguez, MS, PhD
Senior Investigator, Head of Bioprocess Development
View full AI Proteins profile